These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 27085895)

  • 1. Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes.
    Li G; Mukherjee D; Navarro I; Ashpole NE; Sherwood JM; Chang J; Overby DR; Yuan F; Gonzalez P; Kopczynski CC; Farsiu S; Stamer WD
    Eur J Pharmacol; 2016 Sep; 787():20-31. PubMed ID: 27085895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent effects of netarsudil, a Rho-kinase inhibitor, on the distal outflow tract.
    Chen S; Waxman S; Wang C; Atta S; Loewen R; Loewen NA
    Graefes Arch Clin Exp Ophthalmol; 2020 Jun; 258(6):1211-1216. PubMed ID: 32372330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans.
    Kazemi A; McLaren JW; Kopczynski CC; Heah TG; Novack GD; Sit AJ
    J Ocul Pharmacol Ther; 2018 Jun; 34(5):380-386. PubMed ID: 29469601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Netarsudil Improves Trabecular Outflow Facility in Patients with Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 2 Study.
    Sit AJ; Gupta D; Kazemi A; McKee H; Challa P; Liu KC; Lopez J; Kopczynski C; Heah T
    Am J Ophthalmol; 2021 Jun; 226():262-269. PubMed ID: 33524367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms.
    Ren R; Li G; Le TD; Kopczynski C; Stamer WD; Gong H
    Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6197-6209. PubMed ID: 27842161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aqueous outflow regulation: Optical coherence tomography implicates pressure-dependent tissue motion.
    Xin C; Wang RK; Song S; Shen T; Wen J; Martin E; Jiang Y; Padilla S; Johnstone M
    Exp Eye Res; 2017 May; 158():171-186. PubMed ID: 27302601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Netarsudil Ophthalmic Solution 0.02%: First Global Approval.
    Hoy SM
    Drugs; 2018 Mar; 78(3):389-396. PubMed ID: 29453668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilocarpine-induced dilation of Schlemm's canal and prevention of lumen collapse at elevated intraocular pressures in living mice visualized by OCT.
    Li G; Farsiu S; Chiu SJ; Gonzalez P; Lütjen-Drecoll E; Overby DR; Stamer WD
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(6):3737-46. PubMed ID: 24595384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma.
    Sturdivant JM; Royalty SM; Lin CW; Moore LA; Yingling JD; Laethem CL; Sherman B; Heintzelman GR; Kopczynski CC; deLong MA
    Bioorg Med Chem Lett; 2016 May; 26(10):2475-2480. PubMed ID: 27072905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological changes to Schlemm's canal and the distal aqueous outflow pathway in monkey eyes with laser-induced ocular hypertension.
    Sosnowik S; Swain DL; Fan S; Toris CB; Gong H
    Exp Eye Res; 2022 Jun; 219():109030. PubMed ID: 35283108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Netarsudil ophthalmic solution 0.02% for the treatment of patients with open-angle glaucoma or ocular hypertension.
    Kopczynski CC; Heah T
    Drugs Today (Barc); 2018 Aug; 54(8):467-478. PubMed ID: 30209441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward in vivo two-photon analysis of mouse aqueous outflow structure and function.
    Gonzalez JM; Ko MK; Masedunskas A; Hong YK; Weigert R; Tan JCH
    Exp Eye Res; 2017 May; 158():161-170. PubMed ID: 27179411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis.
    Li G; Lee C; Read AT; Wang K; Ha J; Kuhn M; Navarro I; Cui J; Young K; Gorijavolu R; Sulchek T; Kopczynski C; Farsiu S; Samples J; Challa P; Ethier CR; Stamer WD
    Elife; 2021 Mar; 10():. PubMed ID: 33783352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microstructure visualization of conventional outflow pathway and finite element modeling analysis of trabecular meshwork.
    Zhang J; Ren L; Mei X; Xu Q; Zheng W; Liu Z
    Biomed Eng Online; 2016 Dec; 15(Suppl 2):162. PubMed ID: 28155681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma.
    Lin CW; Sherman B; Moore LA; Laethem CL; Lu DW; Pattabiraman PP; Rao PV; deLong MA; Kopczynski CC
    J Ocul Pharmacol Ther; 2018; 34(1-2):40-51. PubMed ID: 28609185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.
    Rao PV; Deng PF; Kumar J; Epstein DL
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1029-37. PubMed ID: 11274082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current therapeutic options and treatments in development for the management of primary open-angle glaucoma.
    Liebmann JM; Lee JK
    Am J Manag Care; 2017 Sep; 23(15 Suppl):S279-S292. PubMed ID: 29164845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of latrunculin-B on outflow facility and trabecular meshwork structure in human eyes.
    Ethier CR; Read AT; Chan DW
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):1991-8. PubMed ID: 16639007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Small Molecule Inhibitor of VE-PTP Activates Tie2 in Schlemm's Canal Increasing Outflow Facility and Reducing Intraocular Pressure.
    Li G; Nottebaum AF; Brigell M; Navarro ID; Ipe U; Mishra S; Gomez-Caraballo M; Schmitt H; Soldo B; Pakola S; Withers B; Peters KG; Vestweber D; Stamer WD
    Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):12. PubMed ID: 33315051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research.
    Rao PV; Pattabiraman PP; Kopczynski C
    Exp Eye Res; 2017 May; 158():23-32. PubMed ID: 27593914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.